Automation cannabis Medicinal Genomics provides automated qPCR microbial testing solutions for cannabis and natural products, presenting a clear opportunity to expand into additional regulated sectors that require fast, validated contaminant screening at scale.

In-house sequencing With in-house DNA sequencing capabilities and a bioinformatics team, there is potential to offer end-to-end genomics services beyond testing, including strain verification, safety profiling, and genetic identification for quality assurance programs.

Regulatory positioning Their history with cannabis genome sequencing and regulators positions MGC to partner on compliance-driven testing workflows, labeling, and traceability initiatives that align with industry standards and blockchain-tracked DNA data.

Strategic partnerships Past collaborations with laboratories and biotech firms (Bio Molecular Systems, UgenTec) indicate a readiness to integrate with third-party platforms; sales efforts could target lab networks, processors, and cultivators seeking scalable automation and software interoperability.

Education and events Upcoming Innovation & Investment Summit activities and educational workshops create openings for sponsored demonstrations, training programs, and pilot projects to convert attendees into customers for microbial testing and genomics-enabled quality control.